ARTICLE | Company News
Maxygen, Aventis Pasteur vaccine deal
November 5, 2001 8:00 AM UTC
MAXY and AVE subsidiary Aventis Pasteur signed a 3-year deal to develop vaccines for an undisclosed target using MAXY's MolecularBreeding directed molecular evolution technologies. MAXY will receive l...